Core K: Translational Virology
核心 K:转化病毒学
基本信息
- 批准号:9906067
- 负责人:
- 金额:$ 34.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAntibodiesAreaBasic ScienceBiologicalBiological AssayBlindedBloodBlood specimenBrainCell CountCell SurvivalCerebrospinal FluidCertificationClinicalClinical SciencesCollectionDataData ReportingDevelopmentE-learningElementsEnsureFundingGenomicsGenotypeGoalsGrantHIVHIV InfectionsHIV-1IndividualInstitutesInternationalLaboratoriesLaboratory ProceduresLeadershipLeukapheresisLinkLogisticsMeasuresMethodsModernizationMultilingualismPriceProceduresProcessPublicationsQuality ControlRecoveryResearchResearch PersonnelSafetySamplingServicesShippingShipsSiteSkinSourceSpecimenSpecimen HandlingSwabSystemTechniquesTestingTrainingTraining ActivityTranslatingUnited States National Institutes of HealthUrineViral Load resultWorkbasebiobankclinical investigationclinically relevantcostcost effectivedesigngenital secretionlymph node biopsymembernext generationnucleic acid detectionprocedure safetyprogramsquality assurancerectalvirology
项目摘要
Project Summary/Abstract
Core K - Modern HIV research efforts require reliable links between clinical and basic science investigators.
These links include characterization and access to clinical specimens, laboratory based assays designed for
clinical specimens, interpretation and management of generated data, and training in these areas. The
Translational Virology (TV) Core of the San Diego (SD) CFAR is designed to be this reliable and cost-effective
link that provides added value to HIV research within our Center. The TV Core accomplishes this goal for a
wide range of HIV research-related activities involving emerging and senior investigators, established and
burgeoning programs, clinical and basic science investigators, domestic and international efforts, NIH and
other funders, etc.
Over the past 4 years, the TV Core has provided services to 199 investigators, contributed to 168 publications,
supported investigators funded by 14 NIH institutes, and trained 127 individuals in safe laboratory procedures
for working with HIV. Specifically, the TV Core provides services through four defined units that work closely
with other CFAR Cores, as outlined:
(1) Specimen Unit: obtains, processes, tracks, ships and cryostores samples. (Primary collaborating Core:
Clinical Investigation Core).
(2) Assay Unit: develops and provides a wide-range of clinically-relevant assays (HIV genotyping, viral loads,
antibody and nucleic acid detection, etc.). (Primary collaborating Core: Genomics and Sequencing).
(3) Quality Control Unit: provides quality control procedures for domestic and international CFAR-affiliated
investigators, and analytical support for generated data. (Primary collaborating Core: BAM Cores).
(4) Training Unit: provides training and certification in BL2 and BL3 safety and procedures, specimen
processing, PCR, genotyping techniques, and laboratory quality assurance. (Primary collaborating Cores:
Developmental and International Cores).
项目总结/摘要
核心K -现代艾滋病毒研究工作需要临床和基础科学研究人员之间的可靠联系。
这些链接包括临床标本的表征和访问,
临床标本、生成数据的解释和管理以及这些领域的培训。的
圣地亚哥(SD)CFAR的翻译病毒学(TV)核心旨在实现这种可靠性和成本效益
链接,为我们中心内的艾滋病毒研究提供附加值。TV Core实现了这一目标,
涉及新的和高级研究人员的广泛的艾滋病毒研究相关活动,
新兴的项目,临床和基础科学研究人员,国内和国际的努力,NIH和
其他投资者等等。
在过去4年中,电视核心向199名调查人员提供了服务,为168份出版物撰稿,
支持由14个NIH研究所资助的研究人员,并对127人进行了安全实验室程序培训
for working加工with HIV艾滋病毒.具体来说,TV Core通过四个定义的单元提供服务,
与其他CFAR核心,概述如下:
(1)样本股:获取、处理、跟踪、运输和冷冻样本。(主要合作伙伴:
临床研究核心)。
(2)检测单元:开发并提供广泛的临床相关检测(HIV基因分型,病毒载量,
抗体和核酸检测等)。(主要合作核心:基因组学和测序)。
(3)质量控制部门:为国内和国际CFAR附属公司提供质量控制程序
调查员和对生成数据的分析支持。(主要合作核心:BAM核心)。
(4)培训部门:提供BL 2和BL 3安全和程序方面的培训和认证,样本
处理、PCR、基因分型技术和实验室质量保证。(主要合作伙伴:
发展和国际核心)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Gianella Weibel其他文献
Sara Gianella Weibel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Gianella Weibel', 18)}}的其他基金
Sex-differences in HIV persistence and Immune Dynamics during Reproductive Aging
生殖衰老过程中艾滋病毒持久性和免疫动态的性别差异
- 批准号:
10838316 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Impact of Reproductive Aging On HIV Persistence and Inflammation
生殖衰老对艾滋病毒持续性和炎症的影响
- 批准号:
10433074 - 财政年份:2021
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of CMV Replication on HIV Persistence
CMV 复制对 HIV 持续存在的机制
- 批准号:
10012877 - 财政年份:2020
- 资助金额:
$ 34.99万 - 项目类别:
The HIV-associated Opioid Micro-Environment (HOME) Project
HIV 相关阿片类药物微环境 (HOME) 项目
- 批准号:
10056153 - 财政年份:2020
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of CMV Replication on HIV Persistence
CMV 复制对 HIV 持续存在的机制
- 批准号:
10241944 - 财政年份:2020
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of CMV Replication on HIV Persistence
CMV 复制对 HIV 持续存在的机制
- 批准号:
10448351 - 财政年份:2020
- 资助金额:
$ 34.99万 - 项目类别:
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ART
性激素下降对接受 ART 的 HIV 感染妇女中 HIV 持续存在的影响
- 批准号:
9482258 - 财政年份:2017
- 资助金额:
$ 34.99万 - 项目类别:
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ART
性激素下降对接受 ART 的 HIV 感染妇女中 HIV 持续存在的影响
- 批准号:
9568360 - 财政年份:2017
- 资助金额:
$ 34.99万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别: